https://pipelinereview.com/RayzeBio-Secures-108-Million-Series-C-Financing-to-Drive-Forward-Its-Pipeline-of-Targeted-Radiopharmaceuticals-for-Cancer/
RayzeBio Secures $108 Million Series C Financing to Drive Forward Its Pipeline of Targeted Radiopharmaceuticals for Cancer